Insider buying on Jul 29, 2026

On Jul 29, 2026, 21 insiders at 18 companies filed 26 purchases reported on Form 4, worth $37.1M in all, with a median purchase of $30.7K. The largest was Gordon Carl L, Director of Scribe Therapeutics, Inc. (SCTX), who reported buying 1,000,000 shares worth $15.0M. Officers accounted for 4 purchases, directors who are not officers for 11, and 10% owners with no board or officer role for 9. Chief executives and chief financial officers filed 4 purchases: Shepro William B, Chair and CEO, Director of Altisource Portfolio Solutions S.a. (ASPS); Patel Snehal, CEO and CFO, Director, 10% owner of Greenwich LifeSciences, Inc. (GLSI); O'Dowd William IV, Chief Executive Officer, Director of Dolphin Entertainment, Inc. (DLPN) among others. 4 companies showed cluster buying, two or more insiders buying within 7 days: SCTX (6 insiders), NNOX (3 insiders), CIK 1944831 (2 insiders), ASPS (2 insiders). For 10 insiders of 21, this was the first purchase of that company's stock on our record. That is fewer than the 46 purchases filed on Jul 28, 2026. A Form 4 is due within two business days of the trade, so most of these purchases were made earlier in the week. Code P also covers shares bought privately from the company, so one large figure can be a negotiated placement rather than buying on the exchange.